Scharping Mara, Brennenstuhl Heiko, Garbade Sven F, Wild Beate, Posset Roland, Zielonka Matthias, Kölker Stefan, Haun Markus W, Opladen Thomas
Division of Child Neurology and Metabolic Medicine, Centre for Child and Adolescent Medicine, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Department of General Internal Medicine and Psychosomatics, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Children (Basel). 2022 May 12;9(5):712. doi: 10.3390/children9050712.
(1) Background: Phenotypic diversity and long-term health outcomes of individuals with urea cycle disorders (UCDs) have been described in detail. However, there is limited information on the burden on affected families. (2) Methods: To evaluate the family burden in parents with children suffering from UCDs, we used validated questionnaires. Socio-demographic characteristics were evaluated, and an adapted version of the Parental Need Scale for Rare Diseases questionnaire was used. The survey was conducted in families of UCD patients cared for at the University Children's Hospital Heidelberg. (3) Results: From April to November 2021, 59 participants were interviewed (mothers = 34, fathers = 25). The affected patients most frequently suffered from ornithine transcarbamylase deficiency (OTC-D) (female = 12, male = 12), followed by argininosuccinate synthetase deficiency (ASS-D, = 13) and argininosuccinate lyase deficiency (ASL-D, = 8). About one-third of the participants were "dissatisfied" or "extremely dissatisfied" with health professionals' disease knowledge. In addition, 30% of the participants reported a medium or high need for "additional information on the development of their children", and 44% reported a medium or high need "for information on available services". A majority of 68% reported a need for additional support regarding services such as support groups (42%) or psychological counseling (29%). (4) Conclusions: Our study indicates that there is an unmet need for sufficient information about the development of children with UCDs, as well as for information about available support services for families with UCD patients. Furthermore, the results highlight the importance of establishing or improving family-centered care approaches. This pilot study may serve as a template for the assessment of the family burden associated with other inherited metabolic diseases.
(1) 背景:尿素循环障碍(UCDs)患者的表型多样性和长期健康结局已得到详细描述。然而,关于受影响家庭所承受负担的信息有限。(2) 方法:为评估患有UCDs的儿童的父母所承受的家庭负担,我们使用了经过验证的问卷。评估了社会人口学特征,并使用了罕见病父母需求量表问卷的改编版。该调查在海德堡大学儿童医院接受治疗的UCD患者家庭中进行。(3) 结果:2021年4月至11月,对59名参与者进行了访谈(母亲 = 34名,父亲 = 25名)。受影响的患者最常患鸟氨酸转氨甲酰酶缺乏症(OTC - D)(女性 = 12名,男性 = 12名),其次是精氨琥珀酸合成酶缺乏症(ASS - D, = 13名)和精氨琥珀酸裂解酶缺乏症(ASL - D, = 8名)。约三分之一的参与者对医疗专业人员的疾病知识“不满意”或“极其不满意”。此外,30%的参与者报告对“孩子发育的额外信息”有中度或高度需求,44%的参与者报告对“可用服务的信息”有中度或高度需求。68%的大多数人报告需要在诸如支持小组(42%)或心理咨询(29%)等服务方面获得额外支持。(4) 结论:我们的研究表明,对于UCDs患儿发育的充分信息以及UCD患者家庭可用支持服务的信息存在未满足的需求。此外,结果突出了建立或改善以家庭为中心的护理方法的重要性。这项试点研究可作为评估与其他遗传性代谢疾病相关的家庭负担的模板。